Annual Long Term Debt
$140.37 M
-$13.16 M-8.57%
31 December 2023
Summary:
ADMA Biologics annual long term debt is currently $140.37 million, with the most recent change of -$13.16 million (-8.57%) on 31 December 2023. During the last 3 years, it has risen by +$43.07 million (+44.26%). ADMA annual long term debt is now -8.57% below its all-time high of $153.54 million, reached on 31 December 2022.ADMA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$110.19 M
-$30.07 M-21.44%
30 September 2024
Summary:
ADMA Biologics quarterly long term debt is currently $110.19 million, with the most recent change of -$30.07 million (-21.44%) on 30 September 2024. Over the past year, it has dropped by -$41.80 million (-27.50%). ADMA quarterly long term debt is now -28.80% below its all-time high of $154.77 million, reached on 31 March 2023.ADMA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.6% | -27.5% |
3 y3 years | +44.3% | +8.8% |
5 y5 years | +217.6% | +31.0% |
ADMA Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -8.6% | +44.3% | -28.8% | +8.8% |
5 y | 5 years | -8.6% | +217.6% | -28.8% | +31.0% |
alltime | all time | -8.6% | +3447.1% | -28.8% | >+9999.0% |
ADMA Biologics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $110.19 M(-21.4%) |
June 2024 | - | $140.26 M(-0.1%) |
Mar 2024 | - | $140.33 M(-0.0%) |
Dec 2023 | $140.37 M(-8.6%) | $140.37 M(-7.6%) |
Sept 2023 | - | $151.99 M(+1.0%) |
June 2023 | - | $150.53 M(-2.7%) |
Mar 2023 | - | $154.77 M(+0.8%) |
Dec 2022 | $153.54 M(+50.0%) | $153.54 M(+1.0%) |
Sept 2022 | - | $152.00 M(+0.9%) |
June 2022 | - | $150.68 M(+3.4%) |
Mar 2022 | - | $145.71 M(+42.4%) |
Dec 2021 | $102.33 M(+5.2%) | $102.33 M(+1.0%) |
Sept 2021 | - | $101.28 M(+0.3%) |
June 2021 | - | $100.95 M(+1.1%) |
Mar 2021 | - | $99.83 M(+2.6%) |
Dec 2020 | $97.30 M(+15.1%) | $97.30 M(-2.6%) |
Sept 2020 | - | $99.90 M(+0.4%) |
June 2020 | - | $99.51 M(+1.6%) |
Mar 2020 | - | $97.96 M(+15.9%) |
Dec 2019 | $84.50 M(+91.2%) | $84.50 M(+0.5%) |
Sept 2019 | - | $84.09 M(+0.4%) |
June 2019 | - | $83.77 M(+46.4%) |
Mar 2019 | - | $57.23 M(+29.5%) |
Dec 2018 | $44.19 M | $44.19 M(+0.7%) |
Sept 2018 | - | $43.91 M(+0.6%) |
Date | Annual | Quarterly |
---|---|---|
June 2018 | - | $43.63 M(+0.9%) |
Mar 2018 | - | $43.23 M(+0.6%) |
Dec 2017 | $42.97 M(+204.5%) | $42.97 M(+37.9%) |
Sept 2017 | - | $31.16 M(+19.9%) |
June 2017 | - | $25.98 M(+105.4%) |
Mar 2017 | - | $12.65 M(-10.4%) |
Dec 2016 | $14.11 M(-10.2%) | $14.11 M(-9.6%) |
Sept 2016 | - | $15.61 M(-21.4%) |
June 2016 | - | $19.87 M(+25.4%) |
Mar 2016 | - | $15.85 M(+0.8%) |
Dec 2015 | $15.72 M(+6.5%) | $15.72 M(+0.8%) |
Sept 2015 | - | $15.59 M(+0.8%) |
June 2015 | - | $15.47 M(+2.6%) |
Mar 2015 | - | $15.07 M(+2.2%) |
Dec 2014 | $14.75 M(+191.4%) | $14.75 M(+46.8%) |
Sept 2014 | - | $10.05 M(+1.5%) |
June 2014 | - | $9.90 M(+0.3%) |
Mar 2014 | - | $9.87 M(+94.9%) |
Dec 2013 | $5.06 M(+27.9%) | $5.06 M(+0.4%) |
Sept 2013 | - | $5.04 M(+0.4%) |
June 2013 | - | $5.02 M(+0.4%) |
Mar 2013 | - | $5.00 M(+26.4%) |
Dec 2012 | $3.96 M | $3.96 M(+4779.7%) |
Sept 2012 | - | $81.10 K(-3.2%) |
June 2012 | - | $83.80 K(-3.3%) |
Mar 2012 | - | $86.70 K |
FAQ
- What is ADMA Biologics annual long term debt?
- What is the all time high annual long term debt for ADMA Biologics?
- What is ADMA Biologics annual long term debt year-on-year change?
- What is ADMA Biologics quarterly long term debt?
- What is the all time high quarterly long term debt for ADMA Biologics?
- What is ADMA Biologics quarterly long term debt year-on-year change?
What is ADMA Biologics annual long term debt?
The current annual long term debt of ADMA is $140.37 M
What is the all time high annual long term debt for ADMA Biologics?
ADMA Biologics all-time high annual long term debt is $153.54 M
What is ADMA Biologics annual long term debt year-on-year change?
Over the past year, ADMA annual long term debt has changed by -$13.16 M (-8.57%)
What is ADMA Biologics quarterly long term debt?
The current quarterly long term debt of ADMA is $110.19 M
What is the all time high quarterly long term debt for ADMA Biologics?
ADMA Biologics all-time high quarterly long term debt is $154.77 M
What is ADMA Biologics quarterly long term debt year-on-year change?
Over the past year, ADMA quarterly long term debt has changed by -$41.80 M (-27.50%)